CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
CT vendors have diverged this year as never before, choosing technological paths to new generations of scanners that reflect their own particular engineering strengths and history of R&D. Core developments by each have translated into novel capabilities. Software and mechanical fixes have countered weaknesses.
This collection of articles produced by the vendors provides a glimpse of how their products will be addressed on the RSNA exhibit floor, as well as insights to how each compares with the others.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.